These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 27274410)

  • 1. Imaging characteristic analysis of metastatic spine lesions from breast, prostate, lung, and renal cell carcinomas for surgical planning: Osteolytic versus osteoblastic.
    Reddington JA; Mendez GA; Ching A; Kubicky CD; Klimo P; Ragel BT
    Surg Neurol Int; 2016; 7(Suppl 13):S361-5. PubMed ID: 27274410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Semiquantitative assessment of osteoblastic, osteolytic, and mixed lytic-sclerotic bone lesions on fluorodeoxyglucose positron emission tomography/computed tomography and bone scintigraphy.
    Gurkan G; Sarikaya I; Sarikaya A
    World J Nucl Med; 2019; 18(2):132-136. PubMed ID: 31040743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET Tracer
    Oka S; Kanagawa M; Doi Y; Schuster DM; Goodman MM; Yoshimura H
    Theranostics; 2017; 7(7):2048-2064. PubMed ID: 28656060
    [No Abstract]   [Full Text] [Related]  

  • 5. 11C-choline PET/CT identifies osteoblastic and osteolytic lesions in patients with metastatic prostate cancer.
    Ceci F; Castellucci P; Graziani T; Schiavina R; Chondrogiannis S; Bonfiglioli R; Costa S; Virgolini IJ; Rubello D; Fanti S; Colletti PM
    Clin Nucl Med; 2015 May; 40(5):e265-70. PubMed ID: 25783519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of the Different Primary Cancers and Different Types of Bone Metastasis on the Lesion-based Artificial Neural Network Value Calculated by a Computer-aided Diagnostic System, BONENAVI, on Bone Scintigraphy Images.
    Isoda T; BaBa S; Maruoka Y; Kitamura Y; Tahara K; Sasaki M; Hatakenaka M; Honda H
    Asia Ocean J Nucl Med Biol; 2017; 5(1):49-55. PubMed ID: 28840139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mixed metastatic lung cancer lesions in bone are inhibited by noggin overexpression and Rank:Fc administration.
    Feeley BT; Liu NQ; Conduah AH; Krenek L; Roth K; Dougall WC; Huard J; Dubinett S; Lieberman JR
    J Bone Miner Res; 2006 Oct; 21(10):1571-80. PubMed ID: 16995812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical relevance of 18F-FDG-negative osteoblastic metastatic bone lesions noted on PET/CT in breast cancer patients.
    Al-Muqbel KM; Yaghan RJ; Al-Omari MH; Rousan LA; Dagher NM; Al Bashir S
    Nucl Med Commun; 2016 Jun; 37(6):593-601. PubMed ID: 26813990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A bone metastasis model with osteolytic and osteoblastic properties of human lung cancer ACC-LC-319/bone2 in natural killer cell-depleted severe combined immunodeficient mice.
    Otsuka S; Hanibuchi M; Ikuta K; Yano S; Goto H; Ogino H; Yamada T; Kakiuchi S; Nishioka Y; Takahashi T; Sone S
    Oncol Res; 2009; 17(11-12):581-91. PubMed ID: 19806789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer-secreted hsa-miR-940 induces an osteoblastic phenotype in the bone metastatic microenvironment via targeting ARHGAP1 and FAM134A.
    Hashimoto K; Ochi H; Sunamura S; Kosaka N; Mabuchi Y; Fukuda T; Yao K; Kanda H; Ae K; Okawa A; Akazawa C; Ochiya T; Futakuchi M; Takeda S; Sato S
    Proc Natl Acad Sci U S A; 2018 Feb; 115(9):2204-2209. PubMed ID: 29440427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation of Predominantly Osteoblastic and Osteolytic Spine Metastases by Using Susceptibility-weighted MRI.
    Böker SM; Adams LC; Bender YY; Fahlenkamp UL; Wagner M; Hamm B; Makowski MR
    Radiology; 2019 Jan; 290(1):146-154. PubMed ID: 30375926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thoracic Temporal Subtraction Three Dimensional Computed Tomography (3D-CT): Screening for Vertebral Metastases of Primary Lung Cancers.
    Iwano S; Ito R; Umakoshi H; Karino T; Inoue T; Li Y; Naganawa S
    PLoS One; 2017; 12(1):e0170309. PubMed ID: 28095493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fasting Enhances the Contrast of Bone Metastatic Lesions in
    Oka S; Kanagawa M; Doi Y; Schuster DM; Goodman MM; Yoshimura H
    Int J Mol Sci; 2017 Apr; 18(5):. PubMed ID: 28468238
    [No Abstract]   [Full Text] [Related]  

  • 14. Detection of bone metastases in breast cancer by 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions.
    Cook GJ; Houston S; Rubens R; Maisey MN; Fogelman I
    J Clin Oncol; 1998 Oct; 16(10):3375-9. PubMed ID: 9779715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wnt1 induces osteoblastic changes in a well-established osteolytic skeletal metastatic model derived from breast cancer.
    Sugyo A; Tsuji AB; Sudo H; Sugiura Y; Koizumi M; Higashi T
    Cancer Rep (Hoboken); 2023 Dec; 6(12):e1909. PubMed ID: 37840014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fusion of metabolic function and morphology: sequential [18F]fluorodeoxyglucose positron-emission tomography/computed tomography studies yield new insights into the natural history of bone metastases in breast cancer.
    Du Y; Cullum I; Illidge TM; Ell PJ
    J Clin Oncol; 2007 Aug; 25(23):3440-7. PubMed ID: 17592153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of zoledronate to treat osteoblastic versus osteolytic lesions in a severe-combined-immunodeficient mouse model.
    Lee YP; Schwarz EM; Davies M; Jo M; Gates J; Zhang X; Wu J; Lieberman JR
    Cancer Res; 2002 Oct; 62(19):5564-70. PubMed ID: 12359769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved detection of bone metastases from lung cancer in the thoracic cage using 5- and 1-mm axial images versus a new CT software generating rib unfolding images: comparison with standard ¹⁸F-FDG-PET/CT.
    Homann G; Mustafa DF; Ditt H; Spengler W; Kopp HG; Nikolaou K; Horger M
    Acad Radiol; 2015 Apr; 22(4):505-12. PubMed ID: 25586709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Volume of Lytic Vertebral Body Metastatic Disease Quantified Using Computed Tomography-Based Image Segmentation Predicts Fracture Risk After Spine Stereotactic Body Radiation Therapy.
    Thibault I; Whyne CM; Zhou S; Campbell M; Atenafu EG; Myrehaug S; Soliman H; Lee YK; Ebrahimi H; Yee AJ; Sahgal A
    Int J Radiat Oncol Biol Phys; 2017 Jan; 97(1):75-81. PubMed ID: 27843032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of Hormone Receptor Status on Spinal Metastatic Lesions in Patients with Breast Cancer.
    Lin J; Goldstein L; Nesbit A; Chen MY
    World Neurosurg; 2016 Jan; 85():42-8. PubMed ID: 26260940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.